Výsledky vyhledávání - "Michele Sharr-McMahon"

A randomized, open-label, phase II study of CC-486 (oral azacitidine), alone or in combination with durvalumab (MEDI4736), in patients (pts) with myelodysplastic syndromes (MDS) unresponsive to prior parenteral azacitidine or decitabine

Autor: Du Hung Lam, C.L. Beach, Lewis R. Silverman, Rami S. Komrokji, Guillermo Garcia-Manero, Stefan Faderl, Ghulam J. Mufti, John F. Seymour, Pierre Fenaux, Michele Sharr-McMahon

Publikováno v: Journal of Clinical Oncology. 34:TPS7078-TPS7078

TPS7078Background: Whileparenteral hypomethylating agents (HMAs) induce hematologic response in ~50% of pts with IPSS higher-risk MDS, options are very limited for nonresponding pts who are at high...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::152eb74d3c871dc88652a765fd6f7937
https://doi.org/10.1200/jco.2016.34.15_suppl.tps7078

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání